| Accession |
GSE191176
|
| Status |
2021/12/19 |
| Title |
A novel anti-influenza combined therapy assessed by single cell RNA-sequencing |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing |
| Summary |
To develop a novel treatment against influenza, we combined virucidal sialylated cyclodextrins with interferon lambda and demonstrated, in human airway epithelia, that the two compounds inhibit the replication of a clinical H1N1 strain more efficiently when administered together rather than alone. We investigated the mechanism of action of the combined treatment by single cell RNA sequencing analysis and found that both the single and combined treatments impair viral replication to different extents across distinct epithelial cell types. We also showed that each cell type comprises multiple sub-types, whose proportions are altered by H1N1 infection, and assess the ability of the treatments to restore them. |
| Samples |
| GSM ID |
Sample info |
Characteristics |
Description |
|
GSM5740432
|
Infected + 6'SLN-CD |
donors:Healthy donors; infection:Influenza A virus; treatment:6'SLN-CD |
S2 |
|
GSM5740433
|
Infected + IFN lambda |
donors:Healthy donors; infection:Influenza A virus; treatment:IFN lambda |
S3 |
|
GSM5740434
|
Infected + 6'SLN-CD + IFN lambda |
donors:Healthy donors; infection:Influenza A virus; treatment:6'SLN-CD and IFN lambda |
S4 |
|
GSM5740435
|
Mock Steady State |
donors:Healthy donors; infection:None; treatment:None |
S5 |
|
GSM5740436
|
Infected Untreated |
donors:Healthy donors; infection:Influenza A virus; treatment:None |
S1 |
|
GSM5740437
|
Mock + 6'SLN-CD + IFN lambda |
donors:Healthy donors; infection:None; treatment:6'SLN-CD and IFN lambda |
S6 |
|
| Platform |
GPL20301 : Illumina HiSeq 4000 (Homo sapiens) |
| Literature |
36216966 |
| Download |
Download scRNA Analysis Data
|
|
scRNA-seq UMAP
|
|
Virus Dataset Detail
